Shaw, K. L., Garabedian, E., Sokolic, R., Barman, P., Davila, A., Silvin, C., … Kohn, D. B. (2015). 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector. In Molecular Therapy (Vol. 23, pp. S13–S14). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)33634-6

Shaw, Kit L., Elizabeth Garabedian, Rob Sokolic, Provaboti Barman, Alejandra Davila, Christopher Silvin, Satiro de Oliveira, et al. “30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector.” In Molecular Therapy, 23:S13–14. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33634-6.

Shaw KL, Garabedian E, Sokolic R, Barman P, Davila A, Silvin C, et al. 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector. In: Molecular Therapy. Elsevier BV; 2015. p. S13–4.

Shaw, Kit L., et al. “30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S13–14. Crossref, doi:10.1016/s1525-0016(16)33634-6.

Shaw KL, Garabedian E, Sokolic R, Barman P, Davila A, Silvin C, de Oliveira S, Shah AJ, Terrazas D, Carbonaro D, Geiger S, Mishra S, Cooper A, Smogorzewska M, Jagadeesh J, Hershfield MS, Wayne A, Crooks GM, Moore T, Candotti F, Kohn DB. 30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a γ-Retroviral Vector. Molecular Therapy. Elsevier BV; 2015. p. S13–S14.